EPISPOT Detection of Circulating Prostate Cells Among Adenocarcinoma Patients
- Conditions
- Adenocarcinoma of the Prostate
- Registration Number
- NCT01402154
- Lead Sponsor
- Centre Hospitalier Universitaire de Nīmes
- Brief Summary
The primary objective of this study is to evaluate the predictive value (in terms of remission) of a new technique for detecting circulating, functional, prostate cells among patients with localized adenocarcinoma of the prostate, and prior to any treatment.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Male
- Target Recruitment
- 361
- The patient must have given his/her informed and signed consent
- The patient must be insured or beneficiary of a health insurance plan
- Histologically proven presence of prostate adenocarcinoma
- Localized disease on digital rectal examination
- Cancer without extensions
- Acceptance of a curative treatment by the patient
- The patient is participating in another study
- The patient is in an exclusion period determined by a previous study
- The patient is under judicial protection, under tutorship or curatorship
- The patient refuses to sign the consent
- It is impossible to correctly inform the patient
- The patient is taking a hormone-modifying treatment
- Patient taking adrogenic supplements
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The difference between AUCs for the EPISPOT and Cellsearch Techniques 1 day The difference between the AUCs (area under the curve) for the EPISPOT and Cellsearch techniques for detecting functional, circulating prostate cells
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (5)
CHU de Nîmes - Hôpital Universitaire Carémeau
🇫🇷Nîmes Cedex 09, Gard, France
CHU de Montpellier - Hôpital Lapeyronie - Plateforme LCCRH
🇫🇷Montpellier Cedex 05, France
CHU de Montpellier - Hôpital Lapeyronie
🇫🇷Montpellier Cedex 05, France
Clinique Beau Soleil
🇫🇷Montpellier, France
Centre Regional de Lutte Contre le Cancer - Val d'Aurelle - Paul Lamarque
🇫🇷Montpellier, France
CHU de Nîmes - Hôpital Universitaire Carémeau🇫🇷Nîmes Cedex 09, Gard, France